Tripp Amos Headshot

Tripp Amos: Board of Directors

Protect your reimbursements with FDA Approved XR-29 Does Check

Scannerside teams with Sapheneia

Sapheneia and Scannerside unite to deliver the most cost- effective, single-source solution providing greater patient safety while helping you comply with new regulations. Read More

In the News

9/5/2017

Sapheneia / Scannerside Announces FDA 510 (K) Clearance for New 2nd Gen XR29 Dose Check

09/01/2016

Sapheneia USA Expands into New Corporate Office in Colorado